Muscular Dystrophy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a condition called Myotonic Dystrophy Type 1 (DM1), either through genetic testing and/or based on symptoms — even if you have no symptoms yet, or if you chose not to have genetic testing done.
- You are an "unaffected" participant, meaning you are not known to have myotonic dystrophy or any other muscular dystrophy, and you may not have had genetic testing.
- You are able to give your own consent to take part in the study.
- You are male or female and are 18 years of age or older.
Who may not be able to join:
- You have a history of a weakened immune system, pre-existing liver or kidney disease, HIV, or hepatitis B and/or C.
- You have taken blood-thinning (anticoagulant) medications within the past 60 days before a spinal fluid collection procedure, or anti-platelet drugs (such as aspirin or similar medicines) within the past 7 days before a blood draw.
- You have any metal inside your body, such as a pacemaker, defibrillator, certain heart valves or stents, an artificial joint, an aneurysm clip, or an inner ear device; or you have a history of working with sheet metal or have metal shrapnel in your body — all of which would make an MRI scan unsafe.
- You are pregnant, as MRI scans may affect an unborn baby.
- There are signs of increased pressure in the brain or an active infection, or your platelet count (a measure of blood clotting cells) is below 50,000 — which would make a spinal fluid collection procedure unsafe (confirm with trial site).
- You are unwilling or unable to provide written consent to participate.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thurman M Wheeler, MD, Massachusetts General Hospital
Phone: 617-726-7506
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Extracellular RNA splice variants in biofluids
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.